New AI-powered experience removes the time-to-evidence barrier, enabling healthcare leaders to better understand and make informed decisions based on whatโs happening in care today BELLEVUE, Wash.โApril 28, 2026โ Truveta today announced Truveta Intelligence, a new...
Providence President and CEO brings extensive experience advancing innovation, operations, and patient-centered care at scale. BELLEVUE, Wash.โ March 31, 2026โGrounded in its mission of Saving Lives with Data, Truveta today announced the appointment of Erik Wexler,...
Veteran healthcare finance executive brings decades of experience advancing disciplined value creation. BELLEVUE, Wash.โ March 31, 2026โGrounded in its mission of Saving Lives with Data, Truveta today announced that Robin Damschroder, FACHE, Executive Vice President,...
BELLEVUE, Wash.โFebruary 10, 2026โA new peer-reviewed study led by Truveta Research and collaborators finds that the US Food and Drug Administrationโs (FDA) March 2024 expansion of semaglutideโs cardiovascular indication was followed by a rapid but short-lived...
Globally recognized pharmacoepidemiologist brings decades of experience advancing real-world evidence for regulatory decision-making. BELLEVUE, Wash.โFebruary 9, 2026โTruveta today announced the appointment of John D. Seeger, PharmD, DrPH, FISPE, a global leader in...
